A previous meta-analysis based on studies published up to 2006 concluded that the association of IGF1 with breast-cancer risk is limited to premenopausal women,47 but our analysis includes four large more recent studies with over 1500 additional patients and shows a clear association of IGF1 with breast-cancer risk in postmenopausal women. The gene discussed is IGF1; the disease is breast carcinoma.